
    
      OUTLINE:

      Patients receive gallium Ga 68-labeled PSMA-11 intravenously (IV) then undergo PET/CT over
      2-3 minutes per bed position at baseline. Patients receiving systemic therapy undergo an
      additional 68Ga-PSMA-11 PET/CT scan 6 weeks after initiating therapy.

      After the completion of study, patients are followed for up to 5 years.
    
  